Press Releases Year None2024202320222021202020192018201720162015201420132012 February 27, 2024 Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update January 16, 2024 Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review January 10, 2024 Aclaris Therapeutics Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis Load More »